Cargando…

Response to PD‐1 blockade in a patient with mucosal melanoma of the middle ear: Case report

PD‐1 blockade is a feasible approach in treating mucosal malignant melanomas of the middle ear.

Detalles Bibliográficos
Autores principales:	Komatsuda, Hiroki, Kumai, Takumi, Ueda, Seigo, Hirata‐Nozaki, Yui, Hayashi, Tatsuya, Harabuchi, Yasuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752406/ https://www.ncbi.nlm.nih.gov/pubmed/33363953 http://dx.doi.org/10.1002/ccr3.3424

Ejemplares similares

The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study
por: Sato, Ryosuke, et al.
Publicado: (2022)

Laryngeal recurrence of extranodal NK/T cell lymphoma
por: Kumai, Takumi, et al.
Publicado: (2021)

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
por: Hirata-Nozaki, Yui, et al.
Publicado: (2019)

IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
por: Kono, Michihisa, et al.
Publicado: (2022)

Removal of Coin Cell Lithium Battery Lodged in the Pediatric Pharyngoesophageal Junction by Rigid Esophagoscopy; a Case Report
por: Ominato, Hisataka, et al.
Publicado: (2022)

19th International Symposium on Epstein–Barr Virus and Associated Diseases, 29–30 July 2021, Asahikawa, Japan
por: Kumai, Takumi, et al.
Publicado: (2022)

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
por: Kono, Michihisa, et al.
Publicado: (2022)

Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
por: Hayashi, Ryusuke, et al.
Publicado: (2020)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress
por: Harabuchi, Yasuaki, et al.
Publicado: (2019)

Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein–Barr Virus Relation
por: Takahara, Miki, et al.
Publicado: (2021)

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021)

Antitumor Peptide-Based Vaccine in the Limelight
por: Kumai, Takumi, et al.
Publicado: (2022)

A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
por: Kosaka, Akemi, et al.
Publicado: (2021)

Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor
por: Kumai, Takumi, et al.
Publicado: (2014)

Middle Ear and Eustachian Tube Mucosal Immunology
por: Massa, Helen M., et al.
Publicado: (2015)

Spontaneous Regression of a Middle Ear Melanoma
por: Krebbers, Iris, et al.
Publicado: (2021)

Middle ear mucosal regeneration by tissue-engineered cell sheet transplantation
por: Yamamoto, Kazuhisa, et al.
Publicado: (2017)

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
por: Kumai, Takumi, et al.
Publicado: (2015)

Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis
por: Satoh, Chisei, et al.
Publicado: (2023)

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade
por: Buchbinder, Elizabeth I., et al.
Publicado: (2021)

High response rate to PD-1 blockade in desmoplastic melanomas
por: Eroglu, Zeynep, et al.
Publicado: (2018)

PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV
por: Davar, Diwakar, et al.
Publicado: (2015)

A RARE CASE OF MIDDLE EAR ADENOMA
por: BAKU, MASAYO, et al.
Publicado: (2014)

A Melting Method for RNA Extraction from the Mucosal Membrane of the Mouse Middle Ear
por: Seo, Young Joon, et al.
Publicado: (2015)

Efficacy of Mucosal Cutting Biopsy for the Histopathological Diagnosis of Gastric Submucosal Tumors
por: Adachi, Akihisa, et al.
Publicado: (2019)

PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade
por: Ganbaatar, Otgontuya, et al.
Publicado: (2020)

Large Cholesterol Granuloma of the Middle Ear Eroding into the Middle Cranial Fossa
por: Kuruma, Tessei, et al.
Publicado: (2017)

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
por: Bertrand, Florie, et al.
Publicado: (2017)

Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
por: Derosa, Lisa, et al.
Publicado: (2021)

The Middle Ear
por: Kirchner, John A.
Publicado: (1959)

Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
por: Deken, Marcel A., et al.
Publicado: (2016)

Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma
por: Frias, Alex, et al.
Publicado: (2023)

Identification ACTA2 and KDR as key proteins for prognosis of PD‐1/PD‐L1 blockade therapy in melanoma
por: Wang, Yuchen, et al.
Publicado: (2021)

Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil‐induced autoimmune/inflammatory syndrome
por: Harabuchi, Yasuaki, et al.
Publicado: (2019)

Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation
por: Komatsuda, Hiroki, et al.
Publicado: (2022)

Carcinoma of the Middle Ear
Publicado: (1927)

Middle-Ear Carcinoma
Publicado: (1928)

Middle Ear Papilloma
por: de Menezes Santos Torres, Sandro, et al.
Publicado: (2015)

Osteoma of the middle ear
por: Barbosa, Vinicius Cotta, et al.
Publicado: (2015)

Middle Ear Schwannoma
por: O. R., Jorge Luis Roig, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_21pe6j1lpo64tg7e26kjplpupd